Steven Feinstein to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Steven Feinstein has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.398
-
Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol. 2004 Jun 03; 93(11A):32C-48C.
Score: 0.219
-
In-hospital statin underutilization among high-risk patients: delayed uptake of the 2013 cholesterol guidelines in a U.S. cohort. Hosp Pract (1995). 2017 Feb; 45(1):16-20.
Score: 0.132
-
Noninvasive surrogate markers of atherosclerosis. Am J Cardiol. 2002 Mar 07; 89(5A):31C-43C; discussion 43C-44C.
Score: 0.047